Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.30
+0.75 (7.11%)
At close: May 13, 2026, 4:00 PM EDT
11.30
0.00 (0.00%)
After-hours: May 13, 2026, 4:00 PM EDT
Elicio Therapeutics Employees
Elicio Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
n/a
Profits / Employee
-$1,217,727
Market Cap
207.88M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | 1 | 3.13% |
| Dec 31, 2024 | 32 | 0 | - |
| Dec 31, 2023 | 32 | 9 | 39.13% |
| Dec 31, 2022 | 23 | -1 | -4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Humacyte | 184 |
| Heron Therapeutics | 128 |
| MediWound | 121 |
| Caribou Biosciences | 97 |
| Corbus Pharmaceuticals Holdings | 36 |
| Enlivex | 34 |
| Whitehawk Therapeutics | 23 |
ELTX News
- 2 days ago - Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 13 days ago - Elicio Therapeutics to Present at the Bank of America Healthcare Conference - GlobeNewsWire
- 27 days ago - Elicio Therapeutics Reports Inducement Grants - GlobeNewsWire
- 4 weeks ago - Elicio Therapeutics initiated with a Buy at Ladenburg - TheFly
- 2 months ago - Elicio Therapeutics reports inducement grants - TheFly
- 2 months ago - Elicio Therapeutics price target raised to $17 from $13 at H.C. Wainwright - TheFly
- 2 months ago - Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 2 months ago - Elicio Therapeutics initiated with a Buy at Rodman & Renshaw - TheFly